These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7533397)

  • 1. Comparative analysis of human DAF expression in the tissues of transgenic pigs and man.
    Cozzi E; Langford GA; Wright L; Tucker A; Yannoutsos N; Richards A; Rosengard A; Elsome K; Lancaster R; White DJ
    Transplant Proc; 1995 Feb; 27(1):319-20. PubMed ID: 7533397
    [No Abstract]   [Full Text] [Related]  

  • 2. Production of pigs transgenic for human regulators of complement activation using YAC technology.
    Langford GA; Cozzi E; Yannoutsos N; Lancaster R; Elsome K; Chen P; White DJ
    Transplant Proc; 1996 Apr; 28(2):862-3. PubMed ID: 8623438
    [No Abstract]   [Full Text] [Related]  

  • 3. Expression of human decay accelerating factor in transgenic pigs.
    Cozzi E; Langford GA; Richards A; Elsome K; Lancaster R; Chen P; Yannoutsos N; White DJ
    Transplant Proc; 1994 Jun; 26(3):1402-3. PubMed ID: 7518135
    [No Abstract]   [Full Text] [Related]  

  • 4. Production of pigs transgenic for human regulators of complement activation.
    Yannoutsos N; Langford GA; Cozzi E; Lancaster R; Elsome K; Chen P; White DJ
    Transplant Proc; 1995 Feb; 27(1):324-5. PubMed ID: 7533399
    [No Abstract]   [Full Text] [Related]  

  • 5. Production of pigs transgenic for human decay accelerating factor.
    Langford GA; Yannoutsos N; Cozzi E; Lancaster R; Elsome K; Chen P; Richards A; White DJ
    Transplant Proc; 1994 Jun; 26(3):1400-1. PubMed ID: 7518134
    [No Abstract]   [Full Text] [Related]  

  • 6. High-level tissue specific expression of human CD59, MCP, and DAF proteins from genomic clones in transgenic mice.
    Oldham ER; Velardo MA; Platt JL; Logan JS; Diamond L
    Transplant Proc; 1996 Apr; 28(2):693. PubMed ID: 8623349
    [No Abstract]   [Full Text] [Related]  

  • 7. Endothelial expression of human decay accelerating factor in transgenic pig tissue: a potential approach for human complement inactivation in discordant xenografts.
    Rosengard AM; Cary N; Horsley J; Belcher C; Langford G; Cozzi E; Wallwork J; White DJ
    Transplant Proc; 1995 Feb; 27(1):326-7. PubMed ID: 7533400
    [No Abstract]   [Full Text] [Related]  

  • 8. Expression of human DAF and MCP on pig endothelial cells protects from human complement.
    Carrington CA; Richards AC; Cozzi E; Langford G; Yannoutsos N; White DJ
    Transplant Proc; 1995 Feb; 27(1):321-3. PubMed ID: 7533398
    [No Abstract]   [Full Text] [Related]  

  • 9. Mice transgenic for human CD46 and CD55 are protected from human complement attack.
    Mulder LC; Mora M; Ciccopiedi E; Melli C; Nuti S; Marinucci G; Bruzzone P; Lazzeri M; Lorenzini R; Alfani D
    Transplant Proc; 1995 Feb; 27(1):333-5. PubMed ID: 7533403
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of complement-mediated liver damage and protection in control and transgenic mice for human complement blockers MCP and DAF.
    Mulder LC; Mora M; Lazzeri M; Boschi M; Ciccopiedi E; Marinucci G; Melli CM; Bruzzone P; Alfani D; Cortesini R; Rossini M
    Transplant Proc; 1996 Feb; 28(1):127-9. PubMed ID: 8644143
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell- and tissue-specific expression of a human CD59 minigene in transgenic mice.
    Diamond LE; Oldham ER; Platt JL; Waldmann H; Tone M; Walsh LA; Logan JS
    Transplant Proc; 1994 Jun; 26(3):1239. PubMed ID: 7518115
    [No Abstract]   [Full Text] [Related]  

  • 12. Human MCP and DHF double transgenic mice are protected from human complement attack in an in vivo model.
    Mulder LC; Mora M; Lazzeri M; Boschi M; Ciccopiedi E; Melli C; Bruzzone P; Alfani D
    Transplant Proc; 1996 Apr; 28(2):589. PubMed ID: 8623287
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of transfectant molecules, MCP, DAF, and MCP/DAF hybrid on xenogeneic vascular endothelium.
    Miyagawa S; Shirakura R; Izutani H; Matsumiya G; Nakata S; Matsuda H; Iwata K; Nagasawa S; Terado A; Matsumoto M
    Transplant Proc; 1994 Jun; 26(3):1253-4. PubMed ID: 7518122
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression of complement regulatory factors using heterologous promoters in transgenic mice.
    Kagan D; Platt J; Logan J; Byrne GW
    Transplant Proc; 1994 Jun; 26(3):1242. PubMed ID: 7518118
    [No Abstract]   [Full Text] [Related]  

  • 15. Human complement regulatory proteins in transgenic animals regulate complement activation in xenoperfused organs.
    McCurry KR; Kooyman DL; Diamond LE; Byrne GW; Martin MJ; Logan JS; Platt JL
    Transplant Proc; 1995 Feb; 27(1):317-8. PubMed ID: 7533396
    [No Abstract]   [Full Text] [Related]  

  • 16. Complement regulatory proteins are expressed at low levels in embryonic human, wild type and transgenic porcine neural tissue.
    Harrower TP; Richards A; Cruz G; Copeman L; Dunnett SB; Barker RA
    Xenotransplantation; 2004 Jan; 11(1):60-71. PubMed ID: 14962294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion.
    McCurry KR; Kooyman DL; Diamond LE; Byrne GW; Logan JS; Platt JL
    Transplantation; 1995 Apr; 59(8):1177-82. PubMed ID: 7537395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permanent expression of human CD59 and/or decay-accelerating factor by rat endothelial cells confers protection from human complement-mediated lysis.
    Charreau B; Cassard A; Tesson L; Le Mauff B; Blanchard D; Lublin D; Soulillou JP; Anegon I
    Transplant Proc; 1995 Feb; 27(1):336-7. PubMed ID: 7533404
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro and in vivo studies to prevent hyperacute rejection.
    Miyagawa S; Mikata M; Matsuda H; Ikawa M; Okabe M; Nagasawa S; Matsumoto M; Seya T; Shirakura R
    Transplant Proc; 1996 Apr; 28(2):1031-3. PubMed ID: 8623217
    [No Abstract]   [Full Text] [Related]  

  • 20. Erythroid-specific expression of human CD59 and transfer to vascular endothelial cells.
    Kooyman D; Byrne G; McClellan S; Nielsen D; Kagan D; Coffman T; Masahide T; Waldmann H; Platt J; Logan J
    Transplant Proc; 1994 Jun; 26(3):1241. PubMed ID: 7518117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.